NCT05998343

Brief Summary

Social isolation and loneliness worsens older adults' risk of dementia, quality of life, and death as much as smoking. Older adults are more likely to use emergency services and are also more likely to experience social isolation and loneliness than younger people. The emergency department is a new setting to screen for social isolation and loneliness in older adults and help accordingly. Social isolation and loneliness are experienced differently by different older adults. Different interventions combatting social isolation and loneliness may work better for different people, and little is known about older adult's preferences for specific types of interventions. HOW R U? is an effective and feasible intervention using same-generation peer support offered by trained hospital volunteers to reduce social isolation and loneliness in older adults. In partnership with the Australian developer of HOW R U?, this study will compare an intergenerational HOW R U? intervention using younger volunteers with the same-generation peer support intervention and a waitlist control arm. The investigators partnered with the staff of emergency departments and family medicine clinics to identify people who will benefit from an intervention combatting, and Volunteer Services to recruit volunteers. The investigators hypothesize that the older adults who receive the intergenerational HOW R U? intervention will have a greater improvement in social isolation and loneliness.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
141

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

July 24, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

August 18, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

August 18, 2023

Status Verified

July 1, 2023

Enrollment Period

2 years

First QC Date

July 24, 2023

Last Update Submit

August 16, 2023

Conditions

Keywords

LonelinessSocial IsolationEmergency DepartmentGeriatricsGeriatric PsychiatryFamily MedicineRandomized Clinical Trial

Outcome Measures

Primary Outcomes (1)

  • Change in loneliness using De Jong Gierveld 6-item Loneliness Scale from Baseline to 12 Weeks

    The minimum value is 0 and the maximum value is 6, with the higher value corresponding with a greater degree of loneliness. It is divided into 4 clinically relevant categories: 0-1 = no loneliness, 2-3 = low levels of loneliness, 4-5 = moderate to severe loneliness, and 6 = severe loneliness.

    Measure at baseline, at 12 weeks (primary outcome) and 24 weeks (sustainability)

Secondary Outcomes (7)

  • Change in perceived social support using Lubben Social Network Scale

    Measure at baseline, at 12 weeks and 24 weeks (sustainability)

  • Change in mood using Geriatric Depression Scale

    Measure at baseline, at 12 weeks and 24 weeks (sustainability)

  • Change in Quality of Life using Euro-Qual 5 Dimensions 5 Levels

    Measure at baseline, at 12 weeks and 24 weeks (sustainability)

  • Change in Functional Status using Older Americans Resource Scale

    Measure at baseline, at 12 weeks and 24 weeks (sustainability)

  • Change in self-perceptions of generativity using Loyola Generativity Scale

    Measure at baseline, at 12 weeks and 24 weeks (sustainability)

  • +2 more secondary outcomes

Other Outcomes (1)

  • Feasibility and Process Outcome 1 - Participant preference

    Measure at 12 weeks

Study Arms (3)

HOW R U? intervention delivered by same-generation peer volunteer

EXPERIMENTAL

HOW R U?

Behavioral: Same-Generation Peer Support HOW R U?

HOW R U? intervention delivered by intergenerational volunteer

EXPERIMENTAL
Behavioral: Intergenerational HOW R U?

Waitlist control group

NO INTERVENTION

After the primary outcome assessment at 12 weeks, control group participants will be offered HOW R U? intervention support outside of the main trial. They will be allowed to choose either intergenerational or same-generation versions.

Interventions

1-on-1 discussion over telephone with a trained volunteer aged 19-39 years old who has received training to provide strength-based support sessions weekly for 12 weeks.

HOW R U? intervention delivered by intergenerational volunteer

1-on-1 discussion over telephone with a trained volunteer aged 60 years or older who has received training to provide strength-based support sessions weekly for 12 weeks.

HOW R U? intervention delivered by same-generation peer volunteer

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Any community-dwelling person 70 years of age and older receiving care from the ED, Family Medicine, or Geriatric clinics at the two participating sites (MSH and NYGH) will be eligible.
  • Baseline de Jong loneliness scores of 2.0 will be required for participation in the trial.

You may not qualify if:

  • Age less than 70 years;
  • Patients with communication problems (critically ill, unconscious, language barrier, speech impairment or otherwise unable to provide consent), or admission to a hospital for \> 72 hours.
  • Patients with severe cognitive impairment or those living in nursing homes who are dependent on others for their activity of daily living will be excluded.
  • Patients without any mobile phone or landline.
  • Volunteers:
  • Volunteers will be 60 years of age or older to qualify as peer-support volunteers.
  • Volunteers will be 19-39 years of age to qualify as intergenerational volunteers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mount Sinai Hospital

Toronto, Ontario, M5G 1XS, Canada

RECRUITING

Related Publications (1)

  • Zheng D, Rose L, Borgundvaag B, McLeod SL, Melady D, Mohindra R, Sinha S, Wesson V, Wiesenfeld L, Kolker S, Kiss A, Lowthian JA, Lee JS. Impact of an intergenerational program to improve loneliness and social isolation in older adults initiated at the time of emergency department discharge: study protocol for a three-arm randomized clinical trial. Trials. 2024 Jun 28;25(1):425. doi: 10.1186/s13063-024-08250-2.

MeSH Terms

Conditions

Social IsolationEmergencies

Condition Hierarchy (Ancestors)

Social BehaviorBehaviorDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

David Zheng, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Primary outcomes will be assessed after 12 weeks by a research assistant who is blinded to the intervention group and who has had no prior contact with the participants. Participants will also be instructed not to reveal the intervention they have received to any research staff.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study is a three-arm outcome assessor blinded randomized controlled trial will follow SPIRIT reporting guidelines and is part of a program of research that adheres to the ORBIT model for developing complex behavioural interventions.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 24, 2023

First Posted

August 18, 2023

Study Start

November 1, 2021

Primary Completion

November 1, 2023

Study Completion

February 1, 2024

Last Updated

August 18, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will share

The de-identified individual level data that support the findings of this study will be available on reasonable request from the Principal Investigator Dr. Jacques Lee (Jacques.lee@sinaihealth.ca) to improve scientific transparency, verify the study findings and generating new knowledge. As this research was supported by public funding, request for commercial purposes will require approval of the funding agency.

Time Frame
18 months from study completion

Locations